Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections (Q40405905)
Jump to navigation
Jump to search
scientific article published on October 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections |
scientific article published on October 2005 |
Statements
1 reference
Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections (English)
1 reference
Jacobsen F
1 reference
Mittler D
1 reference
Hirsch T
1 reference
Gerhards A
1 reference
Lehnhardt M
1 reference
Voss B
1 reference
Steinau HU
1 reference
Steinstraesser L
1 reference
1 October 2005
1 reference
1 reference
1494-1502
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference